# AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
> **ANDA208436** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2025-04-08
## Drug
- **FDA Application Number:** ANDA208436
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
- **Generic name:** AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
- **Active ingredients:** AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Prescription
- **Sponsor:** TEVA PHARMS USA INC
- **Manufacturer:** Teva Pharmaceuticals, Inc.
- **First approval:** 2025-04-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208436)
---
*MORVS · CC0 1.0*